Earnings Summary

Zimmer Biomet Holdings, Inc.’s revenue jumped 4.93% since last year same period to $1869.6Mn in the Q2 2023. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated 2.11% jump in its revenue since last 3-months.

Zimmer Biomet Holdings, Inc.’s net profit jumped 36.56% since last year same period to $209.9Mn in the Q2 2023. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated -9.8% fall in its net profits since last 3-months.

Zimmer Biomet Holdings, Inc.’s net profit margin jumped 30.15% since last year same period to 11.23% in the Q2 2023. On a quarterly growth basis, Zimmer Biomet Holdings, Inc. has generated -11.66% fall in its net profit margins since last 3-months.

Zimmer Biomet Holdings, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.83 - a 17.31% jump from last quarter’s estimates.

Zimmer Biomet Holdings, Inc.’s earning per share (EPS) estimates for the current year stand at 1.83.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Zimmer Biomet Holdings, Inc.’s return on assets (ROA) stands at 0.04.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Zimmer Biomet Holdings, Inc.’s return on equity (ROE) stands at 0.04.

Zimmer Biomet Holdings, Inc. declared 0.24 dividend per share during the earnings announcement for Q1 2023.